Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
L.A. Kasatkina, Sonja Rittchen, Eva M. Sturm
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5431-5431
Open Access | Times Cited: 85
Molecular Mechanism of Cannabinoids in Cancer Progression
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3680-3680
Open Access | Times Cited: 69
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 39
The Potential of Cannabichromene (CBC) as a Therapeutic Agent
Diana E. Sepúlveda, Kent E. Vrana, Joshua J. Kellogg, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 206-213
Open Access | Times Cited: 9
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
CIRCE: Web-Based Platform for the Prediction of Cannabinoid Receptor Ligands Using Explainable Machine Learning
Nicola Gambacorta, Fulvio Ciriaco, Nicola Amoroso, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 18, pp. 5916-5926
Closed Access | Times Cited: 22
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
The Complex Interplay between Endocannabinoid System and the Estrogen System in Central Nervous System and Periphery
Antonietta Santoro, Elena Mele, Marianna Marino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 972-972
Open Access | Times Cited: 37
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update
Gabriella Dörnyei, Zsolt Vass, C. Juhàsz, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
Quality of Life and a Surveillant Endocannabinoid System
Ricardo Augusto de Melo Reis, Alinny Rosendo Isaac, Hércules Rezende Freitas, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy
Sumanta Garai, Luciana M. Leo, Anna-Maria Szczesniak, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8104-8126
Closed Access | Times Cited: 27
Therapeutic Potential of Cannabinoids in Glaucoma
Theresa Lindner, Doreen Schmidl, Laura Peschorn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1149-1149
Open Access | Times Cited: 12
Role of EV-mediated neurodegeneration in substance use disorders
Mohit Kumar, Anindita Saha, Agasou Alfonso Rameau, et al.
Current Opinion in Physiology (2025), pp. 100826-100826
Open Access
Regulation of food intake in teleost fish
José L. Soengas, Marta Conde‐Sieira, Ayelén Melisa Blanco
Elsevier eBooks (2025), pp. 125-187
Closed Access
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases
Ramona Meanti, Elena Bresciani, Laura Rizzi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118044-118044
Closed Access
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
Myriam Dao, Arnaud François
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 24
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
Cannabis sativa: A look at protozoa, helminths, insect vectors, and pests
Rhanoica Oliveira Guerra, José Rodrigues do Carmo Neto, Priscilla Elias Ferreira da Silva, et al.
Fitoterapia (2023) Vol. 166, pp. 105467-105467
Closed Access | Times Cited: 10
The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses
Shang-Kok Ng, Dai‐Jung Chung, Li‐Chun Chang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114467-114467
Open Access | Times Cited: 9
Gastrodin Ameliorates Post-Stroke Depressive-Like Behaviors Through Cannabinoid-1 Receptor-Dependent PKA/RhoA Signaling Pathway
Shiquan Wang, Liang Yu, Haiyun Guo, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
Dominik Duczmal, Aleksandra Bazan-Woźniak, Krystyna Niedzielska, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4923-4923
Open Access | Times Cited: 3
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Krzysztof Laudański, Justin Wain
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 558-558
Open Access | Times Cited: 14
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top